In vivo disease models

Models per indication area

• Type I and II diabetes and complications
• Cardiovascular models
• Central nervous system models
• Gastro-intestinal models
• Pain models
• Other disease models

Related services

• Biomarker discovery and validation
• Pharmacokinetics
• Computational bioactivity and toxicology prediciton

In vivo disease models

Verifying the efficacy of your lead molecules is of crucial importance prior to investing further on lead optimization. Disease models help you to select molecules with therapeutic potential for drug development.

We support you in efficacy screening and proof-of-concept studies with validated disease models and state-of-art techniques. Our comprehensive research approach yields more information from a single study. This allows the elimination of unsuitable compounds and provides valuable input for designing regulatory studies.

Our disease models cover following therapeutic areas:

• Type I and II diabetes and complications
• Cardiovascular models
• Central nervous system models
• Gastro-intestinal models
• Pain models
• Other disease models

All our studies are tailored on customer’s request. We also offer development a novel disease models, including the analytics capabilities in SBW, including genomics, proteomics, live imaging, gross and histopathology.

Follow this link to retrive a comprehensive list of our disease models.

Contact us from this link.